BTK and mantle cell lymphoma: For example, Bruton’s tyrosine kinase (BTK) covalent inhibitor Ibrutinib (Pan et al., 2007; 11, Figure 5) is used as a treatment drug for mantle cell lymphoma (Wang et al., 2013).